key: cord-0888560-3kl6cnht authors: Ahmed, Warish; Bertsch, Paul; Bivins, Aaron; Bibby, Kyle; Farkas, Kata; Gathercole, Amy; Haramoto, Eiji; Gyawali, Pradip; Korajkic, Asja; McMinn, Brian R.; Mueller, Jochen; Simpson, Stuart; Smith, Wendy J.M.; Symonds, Erin M.; Thomas, Kevin V.; Verhagen, Rory; Kitajima, Masaaki title: Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater date: 2020-06-05 journal: Sci Total Environ DOI: 10.1016/j.scitotenv.2020.139960 sha: 2c5936eb5fe64a4ceb256c9cded0ff57cf6f8fd7 doc_id: 888560 cord_uid: 3kl6cnht Abstract There is currently a clear benefit for many countries to utilize wastewater-based epidemiology (WBE) as part of ongoing measures to manage the coronavirus disease 2019 (COVID-19) global pandemic. Since most wastewater virus concentration methods were developed and validated for nonenveloped viruses, it is imperative to determine the efficiency of the most commonly used methods for the enveloped severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Municipal wastewater seeded with a human coronavirus (CoV) surrogate, murine hepatitis virus (MHV), was used to test the efficiency of seven wastewater virus concentration methods: (A–C) adsorption-extraction with three different pre-treatment options, (D–E) centrifugal concentration device methods with two different devices, (F) polyethylene glycol (PEG 8000) concentration, and (G) ultrafiltration. MHV was quantified by reverse-transcription quantitative polymerase chain reaction and the concentration efficiency was calculated for each method. The mean MHV recoveries ranged from 26.7 to 65.7%. The most efficient methods were (B) Adsorption-extraction methods, with MgCl2 pre-treatment, and (C) without manipulation (C), most efficiently concentrated MHV. The third most efficient method used the Amicon® Ultra-15 centrifugal device (D) and its recovery efficiency was not statistically different from the most efficient methods. The methods with the worst recovery efficiency included the adsorption extraction method with acidification (A), followed by PEG concentration (F). Our results suggest that absorption-extraction methods with minimal pretreatment or without manipulation can provide suitably rapid, cost-effective and relatively straightforward recovery of enveloped viruses in wastewater. The MHV is a promising process control for SARS-CoV-2 surveillance and can be used as a quality control measure to support community-level epidemic mitigation and risk assessment. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing global pandemic of coronavirus disease 2019 (COVID-19) (Coronavirus Study Group of the International Committee on Taxonomy of Viruses, 2020). The primary transmission routes of SARS-CoV-2 are inhalation of aerosols/droplets and person-to-person contact (Morawska and Cao, 2020; Yu et al., 2020) . There is increasing evidence for the fecal shedding of SARS-CoV-2 and the presence of viral RNA in domestic wastewater Xiao et al., 2020) . Therefore, the presence of SARS-CoV-2 RNA in untreated wastewater suggests that wastewater could be utilized as a tool to monitor for the invasion, prevalence, molecular epidemiology, and potential eradication of SARS-CoV-2 in the community in an approach known as wastewater-based epidemiology (WBE) . The detection of SARS-CoV-2 RNA in untreated domestic wastewater has been reported in Australia , the Netherlands (Medema et al., 2020) , USA (Wu et al., 2020 , Nemudryi et al., 2020 , France (Wuertzer et al., 2020a; , China , Israel (Bar-Or et al., 2020) , Turkey (Kocamemi et al., 2020) , Spain (Randazzo et al., 2020a (Randazzo et al., , 2020b ) and J o u r n a l P r e -p r o o f study, a head-to-head method comparison of virus recovery efficiencies demonstrated differences between an enveloped virus and a nonenveloped virus in lake water in Japan (Haramoto et al., 2009) . Such discrepancies could lead to large errors (i.e., an order of magnitude) in the estimated concentration of SARS-CoV-2 in untreated wastewater. To date, no information is available regarding the SARS-CoV-2 recovery efficiency for the wastewater concentration methods commonly used Kitajima et al. 2020 ). Due to the stringent biosafety requirements of working with SARS-CoV-2, a model virus with similar structural and morphological characteristics provides a useful surrogate for estimating the recovery efficiency of SARS-CoV-2 concentration methods. A handful of non-human coronaviruses (CoVs), porcine epidemic diarrhea virus (Randazzo et al., 2020b) and avian infectious bronchitis virus (Kocamemi et al., 2020) have been used to estimate human CoV recoveries. Data suggested that approximately 11% and 3% of the seeded porcine epidemic diarrhea virus were recovered from untreated and treated wastewater, respectively, with aluminum flocculation-based concentration methods (Randazzo et al., 2020b) . Interestingly, these CoV recoveries were similar to the recoveries of the nonenveloped mengovirus (Randazzo et al., 2020b) , which is often used as a process control for enteric virus detection in environmental samples (da Silva et al., 2007; Sima et al., 2011; Farkas et al., 2018) . Betacoronavirus, which belongs to the same genus as SARS-CoV-2 (Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, 2020), and is responsible for a number of diseases in mice and rats (Roth-Cross et al., 2008) . MHV has been used as a surrogate for human CoV in recovery and persistence studies (Ye et al., 2016) . MHV and other murine viruses (e.g. murine norovirus) have been successfully used as surrogates for many different enveloped and nonenveloped viruses due to their structural and morphological similarities (Casanova et al., 2009; Ye et al., 2016; Patel et al., 2017) , and there are no special laboratory requirements for their use since they are non-pathogenic to humans. In the present study, we evaluated the efficiencies of MHV recovery from wastewater using various virus concentration methods previously used to detect SARS-CoV-2 in wastewater Medema et al., 2020; Wu et al., 2020) . The performance of seven virus concentration methods was estimated and compared by seeding MHV in untreated sewage samples. RT-qPCR J o u r n a l P r e -p r o o f assays were then used to measure MHV concentrations in seeded untreated domestic wastewater samples to identify the relative performance of each method for CoV recovery. The results presented in this study will allow researchers to select an appropriate sensitive concentration method(s) for the recovery of SARS-CoV-2 from domestic wastewater for WBE applications. The enveloped MHV stock was obtained from 20 fecal samples of naturally infected mice. Each MHV positive fecal sample (approximately 250 mg) was suspended into 1 mL of phosphate buffered saline (1 × PBS) and then the samples were pooled together to produce a homogeneous fecal slurry. The slurry was centrifuged at 1,000 × g for 10 min. The pellet was discarded, and the supernatant was stored at -80°C for three days. This supernatant, containing MHV, is referred to as the MHV suspension. The MHV RNA concentration in the fecal suspension was determined using an MHV RT-qPCR assay (see below for detailed methodologies). Briefly, RNA was directly extracted on three occasions from triplicate, 200 µL aliquots of MHV suspension using the RNeasy PowerMicrobiome Kit according to manufacturer instructions with a minor modification (Qiagen, Valencia, CA, USA). The glass beads in the bead tube were replaced with garnet beads which have sharp cutting edges. A sample of untreated wastewater (2 L) was collected from a metropolitan wastewater treatment plant (WWTP) in Brisbane, Australia and transported to laboratory on ice. The wastewater sample was kept in 4°C 24 h. The WWTP treats domestic wastewater from approximately 325,000 people, as well as industrial wastewater. The treatment process consists of primary treatment, a secondary treatment (activated sludge), and disinfection with chlorine and UV. While stormwater also enters the WWP, the study catchment did not receive any precipitation 24 h prior to the wastewater sampling. A 200 µL volume of MHV suspension was added to a 50 mL aliquot of untreated wastewater and subjected to each virus concentration method. J o u r n a l P r e -p r o o f 6 Viruses were concentrated from MHV seeded (n = 3) and unseeded (n = 1) domestic wastewater samples using each of the seven methods as shown in Figure 1 . The unseeded wastewater samples were used to identify background MHV concentrations in wastewater. Methods A, B and C were derived from virus adsorption concentration methods commonly used to concentrate enteric viruses from water/wastewater (Symonds et al., 2014; Ahmed et al., 2015; Ahmed et al., 2020) . Method A began with acidification of sample to pH 4 using 2 N HCl. Method B did not manipulate the sample; it began with measuring the pH of the sample (pH = 6.9). Method C began with the addition of MgCl 2 to the sample to achieve a final concentration of 25 mM MgCl 2 . For Methods A, B and C, samples were then passed through 0.45-µm pore-size, 47-mm diameter electronegative membranes (HAWP04700; Merck Millipore Ltd, Sydney, Australia) via a magnetic filter funnel (Pall Corporation) and filter flask (Merck Millipore Ltd.) (Ahmed et al., 2015) . The membrane was immediately inserted into a 2 mLbead beating tube (followed by RNA extraction described below). Methods D and E were ultrafiltration methods that use centrifugal devices that have previously been used to concentrate viruses from (waste)water (Symonds et al., 2009; Ikner et al., 2011) . Both methods began with the centrifugation of the sample at 4,500 g for 10 min at 4°C to obtain a pellet. For Method D, the supernatant was concentrated using an Amicon® Ultra-15 (30 K) Centrifugal Filter Devices (Merck Millipore Ltd.), which was centrifuged at 4,750 g for 10 min at 4°C. This centrifugal concentration step was repeated three times to pass through the entire supernatant volume (Symonds et al., 2009; Ikner et al., 2011; Ahmed et al., 2015) . The concentrated sample (400 µL) was collected from the sample reservoir with a pipette and transferred into a 2 mL-bead beating tube. For Method E, the supernatant was further centrifuged at 3,500 g for 30 min at 4°C through the Centricon Plus-70 centrifugal filter with a molecular weight cut-off of 10 kDa (Merck Millipore). The concentrated sample (300 µL) was collected from the concentrate collection cup with a pipette and mixed with 100 µL of DNase and RNase free water and transferred into a 2 mL-bead beating tube Medema et al., 2020) . Method F employed PEG precipitation, which is commonly used to concentrate viruses from water matrices (Mull and Hill, 2012; Gyawali et al., 2019; Wu et al., 2020) . In this study, it began with sample centrifugation at 10,000 g for 20 min at 4°C to remove larger particles and debris. The resulting supernatant was transferred to a fresh centrifuge tube and stored at 4°C, while MHV was J o u r n a l P r e -p r o o f 7 isolated from the pellet. The pellet was re-suspended in beef extract (3% w/v) in 0.05 M glycine (pH 9.0) at a ratio of 1:5. The pellet was agitated on a shaking incubator at 200 rpm for 30 min at room temperature. The pellet suspension was then centrifuged at 10,000 g for 10 min at 4 o C and the supernatant was transferred into the centrifuge tube containing supernatant from the initial centrifugation step. The pH of the supernatant mixture was neutralized by the addition of 2 M HCl. PEG 8000 and NaCl were added to the supernatant at ratios of 10% and 2% w/v, respectively. The centrifuge tubes were then incubated at 4°C for 2 h on an orbital shaker set to 120 rpm. Following incubation, the sample was centrifuged at 10,000 g for 30 min at 4°C to obtain a pellet. The supernatant was discarded, and the pellet was resuspended in 800 µL Trizol (Sigma-Aldrich, Sydney, NSW, Australia). Finally, 400 μL of the concentrated sample was transferred to a 2-mL bead beating tube. Method G used ultracentrifugation, which is frequently used to concentrate viruses from (waste)water (Fumian et al., 2010; Ammersbach and Bienzle, 2011, Ye et al., 2016) . In this study, it began with sample centrifugation at 100,000 g for 1 h at 4°C. Supernatant was removed carefully, and the pellet was suspended in 3.5 mL of 0.25 N glycine buffer (pH 9.5). The sample was incubated on ice for 30 min. The sample was neutralized by the addition of 3 mL of 2 × PBS (pH 7.2). The supernatant was clarified by centrifugation (12,000 g for 15 min at 4°C). The virus was recovered by ultracentrifugation at 100,000 g for 1 h at 4°C (Fumian et al., 2010) . The pellet was resuspended in 400 µL of 1 × PBS (pH 7.2) and transferred into a 2-mL bead beating tube. RNA was extracted using the RNeasy PowerMicrobiome Kit with a slight modification (Qiagen). The glass beads in the bead tube were replaced with garnet beads which have sharp cutting edges. In brief, a 650 µL of buffer PM1 and 6.5 µL of beta-Mercaptoethanol (Sigma-Aldrich) were added into each bead beating tube. Bead beating tubes were homogenized using a Precellys 24 tissue homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) at conditions 3 × 20 s at 10,000 rpm at a 10 s interval. Tubes were further centrifuged at 10,000 g for 5 min to pellet the filter debris and beads. 450 μL of sample lysate from the bead beating tube was transferred into rotor adapter (Qiagen) using a QIAcube Connect platform (Qiagen) to obtain a final elution volume of 100 μL of RNA. All RNA samples were stored at -80°C and subjected to RT-qPCR analysis within the same day J o u r n a l P r e -p r o o f of RNA extraction to avoid losses associated with storing, as well as freezing and thawing RNA preparations. A previously published TaqMan-based RT-qPCR assay was used for MHV detection in wastewater concentrate RNA samples (Besselen et al., 2002) . For the MHV RT-qPCR assay, gBlocks gene fragments (double-stranded DNA), containing the 108 bp assay amplicon, were purchased from Separately, three instrument runs were executed on different days to analyze a six-point, ten-fold serial dilution of the MHV assay gBlock (5 × 10 5 to 5 copies/reaction) in triplicate. A standard curve was generated for each instrument run from the log 10 -linear regression of triplicate Cq values. The lowest number of diluted standards detected in triplicate assays was considered the qPCR assay limit of detection (ALOD). The MHV estimated copy numbers for each virus wastewater concentrate sample were corrected for the difference between the double-stranded standard curve material and the single-stranded MHV virus (e.g., divided by 2). The presence of PCR inhibition in virus wastewater concentrate sample RNA was assessed using the Sketa22 qPCR assay (Haugland et al., 2005) after spiking RNA samples with a known copy number (10 4 /reaction) of Oncorhynchus keta (O. keta) DNA as previously described . In order to identify PCR inhibition, O. keta DNA was also added to DNase-and RNase-free water and the mean Cq value was used to set-up a reference point. Subsequently, Sketa22 qPCR assay (for O. keta) was performed in 25 μL reaction mixtures using Bio-Rad CFX96 thermal cycler (Bio-Rad Laboratories), using automatic settings for threshold and baseline. The qPCR assay mixtures Wastewater RNA samples processed with Methods C and D were within the 1 Cq value of the reference Cq value; thus, no evidence of inhibition was identified in the RT-PCR process. The MHV recovery efficiency of each replicate for each concentration method was calculated based upon the copies quantified per by RT-qPCR as follows: Recovery Efficiency (%) = Total viral RNA gene copies recovered in concentrated wastewater Total viral RNA gene copies seeded in wastewater × 100 The mean and standard deviation for each concentration method was calculated. J o u r n a l P r e -p r o o f To minimize qPCR contamination, RNA extraction and RT-qPCR set up were performed in separate laboratories. A method blank was included for each concentration method. A reagent blank was also included during nucleic acid extraction to account for any contamination during extraction. All method and extraction blanks were negative for MHV. The one-way analysis of variance (ANOVA) was used to determine whether there was a difference in MHV recovery among the concentration methods tested and also MHV concentrations in fecal suspensions. Tukey's honest significant difference (HSD) test was used for post-hoc evaluation of group pairings that were significantly different (α = 0.05) using GraphPad software (Prism 8.3, La Jolla, CA, USA). MHV RT-qPCR standard curves had a dynamic linear range of quantification from 5 × 10 5 to 5 copies/reaction. The slope of the standard curves ranged from −3.254 to −3.334 (Table 1 ). The amplification efficiencies ranged from 98.7 to 103% and the correlation coefficient (r 2 ) ranged from 0.992 to 0.995. The assay limit of quantification (i.e., lowest copy number detected 100% of the time) was 5 copies/reaction. The mean log 10 copies of MHV recovered/RT-qPCR reaction for each concentration method used in this study are shown in There is a need for the development of efficient methods to concentrate and detect SARS-CoV-2 from wastewater, which has been identified as a key research need for WBE , La Rosa 2020b . Furthermore, it is important to determine the SARS-CoV-2 concentration method recovery efficiency. First, it can enable the user to select the appropriate method to recover SARS-CoV-2 from wastewater with optimal efficiency. Additionally, characterizing method performance will allow more detailed assessments of the actual SARS-CoV-2 load present in wastewater influent, as well as any given water source receiving (un)treated wastewater. A thorough understanding of SARS-CoV-2 concentration method efficiencies will enable accurate measurements in wastewater and allow public health officials to develop appropriate mitigation strategies needed on a community level. Due to the inherent risks associated with laboratory work with infectious SARS-CoV-2 (WHO, 2020), we used a human CoV surrogate, MHV, belonging to the same genus as SARS-CoV-2 to evaluate concentration method performance. In this study, seven concentration methods were evaluated for their recovery of MHV from wastewater. The benefits and limitations of these methods are summarized in Table 3 . These methods have been previously used to recover nonenveloped enteric viruses from various water matrices but have not been evaluated for their ability to detect and J o u r n a l P r e -p r o o f concentrate enveloped virus to date except for a few instances Medema et al., 2020; Wu et al., 2020) . When reported, recovery efficiencies for nonenveloped viruses varied widely depending on the matrix and the virus (Haramoto et al., 2018) , but analogous information for enveloped viruses is not available. Of the methods tested, two of the adsorption-extraction methods had the most optimal MHV recovery for wastewater samples ( Furthermore, the results of the present study highlight the need to concentrate both liquid and solid fractions of wastewater samples. Interestingly, Method A (adsorption-extraction, with acidification pretreatment) also concentrated both fractions of the sample, but unlike Methods B and C, it required acidification of the sample to pH 4 and yielded the lowest recoveries. It has been reported that sample acidification might affect virus integrity and infectivity (Abdelzaher et al., 2008; Sabatino and Maier, 1980) . This suggests that, unlike other enteric viruses, CoV may be sensitive to low pH. Further J o u r n a l P r e -p r o o f cross-comparison may be required to identify the impacts of acidification and other pre-treatment on the recovery of SARS-CoV-2 from untreated wastewater samples. We found that ultrafiltration using centrifugal concentration devices may also be suitable for the recovery of MHV; however, recovery efficiency varied greatly based upon the centrifugal concentration device utilized (Methods D and E) . Ultrafiltration using centrifugal concentration devices concentrate viruses based on size exclusion rather than electrostatic interactions between negatively charged viruses and electronegative or electropositive membranes. In this method, molecules smaller than the molecular weight cut-off are passed through the membrane by centrifugation; thus, the viruses are collected in the retentate fraction. These methods have been previously used to concentrate viruses from (waste)water (Symonds et al., 2009; Ikner et al., 2011) and recently used for SARS-CoV-2 RNA detection in sewage Medema et al., 2020; Kocamemi et al., 2020 recovery was similar to that obtained for MHV in our study. Such results suggest that a given centrifugal concentration device may also yield variable recoveries for different classes of viruses. In addition to not being the most efficient method for MHV recovery, ultrafiltration using centrifugal concentration devices has a variety of drawbacks. One limitation is that a pre-filtration step at low speed is required to remove most of the larger debris and cells before ultrafilter centrifugation. Such pre-filtration can cause the loss of particle-associated viruses in the pellet. The resultant pellets from Method D and E were analysed for MHV in our study; we observed ~30% loss of MHV during the pre-J o u r n a l P r e -p r o o f filtration step. Furthermore, Method D is time-consuming because the maximum sample volume of these units is 15 mL; hence, repeated centrifugation of 15-20 mL aliquots is required to concentrate a 50-mL sample. While no evidence of RT-qPCR inhibition was identified in this study using Method D, these centrifugal concentration devices may co-concentrate PCR inhibitors. Furthermore, smaller molecular cut-off (i.e., 10 kDA or 30 kDA) device will take significant longer time to process wastewater samples than larger molecular cut-off (i.e., 100 kDA) and also co-concentrate different levels of PCR inhibitors. Finally, centrifugal concentration devices are quite expensive and often not readily available in many countries. Thus, adsorption-extraction methods (Method B and C) may be more logistically feasible and efficient for SARS-COV-2 WBE. Method F (PEG precipitation) appeared to be a promising approach for MHV concentration because it incorporated the concentration of viruses from both the liquid and solid fractions of wastewater, however, it recovered significantly less MHV in comparison to Methods B and C. Different versions of PEG precipitation have been used for the assessment of SARS-CoV-2 in sewage, but the efficiencies were not reported (Wu et al., 2020; Kocamemi et al., 2020; Bar-or et al., 2020) . To the best of our knowledge, only one study reported the MHV recovery (~5%) using PEG precipitation (Ye et al., 2016) , which was much lower than the value obtained in this study. This is likely because in our study PEG method concentrated MHV from both liquid and solid fractions, whereas in the previous study MHV was concentrated only from liquid phase (Ye et al., 2016) . Using PEG concentration methods, Kocamemi et al. (2020) found 1-1.5 log 10reduction in detection due to RT-qPCR inhibition when using this method and it is likely that the coconcentration of inhibitors with these methods explained their lower MHV recoveries. While qPCR inhibition was not observed in our study, the RT process may have been inhibited. In this study, Method G (ultracentrifugation) yielded a mean recovery of 33.5%, which was significantly less than the most efficient methods (Methods B and C) . Wurtzer et al. (2020a and ) used ultracentrifugation to recover SARS-CoV-2 from 11 mL of wastewater but did not provide recovery efficiency data. Ultracentrifugation has been used for decades to concentrate viruses from environmental matrices. It has been reported that ultracentrifugation at 100,000 g is required to pellet This study is the first to evaluate established wastewater virus concentration methodologies for their use to concentrate CoV from wastewater, and ultimately, facilitate WBE. Since free viral RNA can degrade within minutes in wastewater (Limsawat and Ohgaki, 1997) , most of the RNA copies detected in the wastewater virus concentration methods will be most likely from intact virus particles that may or may not be infectious. While we identified superior performance by the adsorption extraction concentration methods, with MgCl 2 pre-treatment and without pre-treatment, it is important to note that the methods performance evaluation was based on small volumes (50 mL) of one municipal WWTP and the use of a surrogate (MHV). It is possible that CoV recovery efficiencies may vary based upon the wastewater matrix characteristics (e.g., concentration of total and dissolved suspended solids). Frequently, it is possible to filter as much as 100-200 mL of wastewater using the adsorption extraction method used in this study. If these larger volumes were filtered, then the adsorptionextraction methods may become less efficient given the increased co-concentration of inhibitors. Also centrifugal concentration device, such as those used in this study, may co-concentrate RT-PCR inhibitors. To obtain information on the RT-PCR inhibitors, 50 mL of distilled water was seeded with MHV and the MHV recovery efficiency was compared to that for the MHV seeded wastewater for Methods C and D. Given that the recovery efficiency was only improved for distilled water by 5-8%, it is unlikely that 50 mL wastewater samples tested in this study had RT-PCR inhibitors. It is likely that the co-concentration of inhibitors from larger volumes will have a minimal influence on CoV recovery but will require further investigation. Furthermore, RNA extraction kit used in this study is equipped with next-generation inhibition removal technology (IRT) which is designed to remove PCR inhibitors effectively for soil and fecal samples. Several methods identified in this preliminary study can be used in conjunction with large-scale primary concentration procedures (2-100 L, such as dead-end or tangential flow hollow fibre J o u r n a l P r e -p r o o f 16 ultrafiltration) as a primary step to reduce filter elution to volumes, which are applicable to molecular detection assays. Furthermore, the focus of future research efforts should be to compare recovery efficiencies of MHV to those of actual SARS-CoV-2, considering the multiple benefits of working with the former as a surrogate. Also, the recovery efficiency of various levels of surrogate CoV or SARS-CoV-2 from large volumes of wastewater needs to be assessed to better understand how these variabilities affect recovery efficiency. Furthermore, the best methods for the recovery of intact virus particles need to be identified. Given the high standard deviations observed in the recoveries of any given method, the use of a process control is highly recommended for assessing and normalizing SARS-CoV-2 concentrations for WBE. MHV is a promising process control, which can be purchased from ATCC and similar companies; however, it may be difficult to obtain this virus in a timely-manner during the pandemic. Other coronaviruses, and/or other viral surrogates, could also be useful process controls for SARS-CoV-2 surveillance; thus, future studies are needed to assess their use as a process control. The culmination of these efforts will aid public health officials, epidemiologist and modellers in assessing incidences of SARS-CoV-2 infection rates at the community scale using WBE approaches, so that appropriate public health response and intervention strategies are deployed. -Use electropositive membrane to avoid pH adjustment. -Pre-filter sample to eliminate debris and lower turbidity, which will allow more sample to pass through the filter. -Use large pore size membrane to process large volume of wastewater sample. Method B -Rapid (<40 m to process a sample). -Concentrate viruses from both solid and liquid phases. -Easy to upscale using 90 mm membranes. -Up to 200 mL sample can be processed depending on the filter size and turbidity of the sample. -Can be applied on field. -Only equipment required is a filtration unit. -Multiple samples can be processed at a time if multiple filtration units are available. -Requires washing and cleaning flasks. -Clogging occurs due to high turbidity. -Specific RNA extraction kit equipped with bead beating step is required. -90 mm filtrations units are expensive. -Pre-filter sample to eliminate debris and lower turbidity, which will allow more sample to pass through the filter. -Use large pore size membrane to process large volume of wastewater sample. Method C -Rapid (<40 m to process a sample). -Concentrate viruses from both solid and liquid phases. -Easy to upscale using 90 mm membranes. -Up to 200 mL sample can be processed depending on the filter size and turbidity of the sample. -Can be applied on field. -Only equipment required is a filtration unit. -Multiple samples can be processed at a time if -Requires washing and cleaning flasks. -Addition of MgCl 2 is required. -Clogging occurs due to high turbidity. Specific RNA extraction kit equipped with beadbeating step is required. -90 mm filtrations units are expensive. -Pre-filter sample to eliminate debris and lower turbidity, which will allow more sample to pass through the filter. -Pre-treating membrane with MgCl 2 may be more effective in recovering viruses from wastewater. -Use large pore size membrane to process large J o u r n a l P r e -p r o o f 26 multiple filtration units are available. volume of wastewater sample Method D -Rapid (1 h depending on the turbidity of the sample). -Only equipment required is a centrifuge (up to 4,750 g). -Concentrate viruses only from liquid fraction. -Ultrafiltration unit is expensive. -Can process up to 15 mL sample at a time. -Multiple filtration units may be needed for high turbidity samples. -Clogging occurs due to high turbidity. -Cannot be applied on field. -Viruses adsorb to the membrane. -Co-concentrate PCR inhibitors. -Use 100 kDa filtration unit to speed up the process and reduce clogging. Method E -Rapid (1 h depending on the turbidity of the sample). -Can process up to 70 mL sample at a time. Only equipment required is a centrifuge (up to 3,500 g). -Concentrate viruses only from liquid fraction. -Ultrafiltration unit is expensive and not available all the time. -Clogging occurs due to high turbidity. -Cannot be applied on field. -Viruses adsorb to the membrane. -Co-concentrate PCR inhibitors. -Use 100 kDa filtration unit to speed up the process and reduce clogging. -CentriPrep (Merck) may be a viable alternative when Centricon is not available. -Similar devices can be sourced from other vendors such as Pall Corporation. Method F -Only equipment required is a centrifuge (up to 10,000 g). -Concentrate viruses from both solid and liquid phases. -Relatively inexpensive. -Large volume of wastewater can be processed. -Time consuming (4-6 h). -Requires handling of hazardous chemical (Trizol). -Cannot be applied on field. -A portion of sample is used to extract RNA leaving target behind. -Elute pellet in PBS to reduce hazard. Method G -Concentrate viruses from both solid and liquid phase. -Per sample processing cost is low. -Time consuming (3 h). -Only a small number (n = 6) of samples can be processed at a time. -Limited volume of samples can be processed. -Requires expensive equipment (ultracentrifuge), which is not available in routine microbiology labs. -Cannot be applied on field. -Requires training to operate ultracentrifuge. -Pre-filter sample to eliminate Sequential concentration of bacteria and viruses from marine waters using a dual membrane system Comparison of concentration methods for quantitative detection of sewage-associated viral markers Novel crAssphage marker genes ascertain sewage pollution in a recreational lake receiving urban stormwater runoff First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: a proof-of-concept for quantitative environmental surveillance Identification of viral pathogen diversity in sewage sludge by metagenome analysis Recent trends on methods for the concentration of viruses from water samples. Current opinion in Environmetal Science & Health The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments MIQE précis: Practical implementation of minimum standard guidelines for fluorescencebased quantitative real-time PCR experiments Making waves: Conronavirus detection, persistence and persistence in the water environment: state of the art and knowledge needs for public health Survival of surrogate 561 coronaviruses in water The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Evaluation of removal of noroviruses during wastewater treatment, using real-time reverse transcription-PCR: different behaviors of genogroups I and II Seasonal and spatial dynamics of enteric viruses in wastewater and in riverine and estuarine receiving waters Methods to determine limit of detection and limit of quantification in quantittaive real-time PCR (qPCR) Detection of rotavirus A in sewage samples using multiplex qPCR and an evaluation of the ultracentrifugation and adsorption-elution methods for virus concentration Evaluation of pepper mild mottle virus as an indicator of human faecal pollution in shellfish and growing waters Development of virus concentration methods for detection of koi herpesvirus in water A review on recent progress in the detection methods and prevalence of human enteric viruses in water New method using a positively charged microporous filter and ultrafiltration for concentration of viruses from tap water Concentration and recovery of viruses from water: a comprehensive review Development of a virus concentration method and its application to detection of enterovirus and Norwalk virus from coastal seawater SARS-CoV-2 in wastewater: State of the knowledge and research needs First data-set on SARS-CoV-2 detection for Istanbul wastewaters in Turkey First detection of SARS-CoV-2 in untreated wastewater in Italy Coronavirus in water environments: Occurrence, persistence and concentration methods -A scoping review Fate of liberated viral RNA in wastewater determined by PCR Influence of salts on virus adsorption to microporous filters Presence of SARS-Coronavirus-2 RNA in sewage and correlation with reported COVID-19 prevalence in the early stage of the epidemic in the Netherlands Airborne transmission of SARS-CoV-2: the world should face the reality Recovery of diverse microbes in high turbidity surface water samples using dead-end ultrafiltration Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater A murine herpesvirus closely related to ubiquitous human herpesvirus causes T-Cell depletion Metropolitan wastewater analysis for COVID-19 epidemiological surveillance SARS-CoV-2 RNA titers in wastewater anticipated COVID-19 occurrence in a low prevalence area Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microgila Differential inactivation of three bacteriophages by acid and alkaline pH used in the membrane adsorption-elution method of virus recovery Membrane-based methods of virus concentration from water: a review of process parameters and their effects on virus recovery Calicivirus removal in a membrane bioreactor wastewater treatment plant Performance of two quantitative PCR methods for microbial source tracking of human sewage and implications for microbial risk assessment in recreational waters Eukaryotic viruses in wastewater samples from the United States A case study of enteric virus removal and insights into the associated risk of water reuse for two wastewater treatment pond systems in Bolivia Evaluation of methods used to concentrate and detect hepatitis A virus in water samples Concentration of viruses from water by membrane chromatography Laboratory biosafety guidance related to coronavirus disease (COVID-19). Interim guidance SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases Evaluation of lockdown impact on SARS-CoV-2 dynamics through viral genome quantification in Paris wastewaters Time course quantitative detection of SARS-CoV-2 in Parisian wastewaters correlates with COVID-19 confirmed cases. medRxiv 10-13 Infectious SARS-CoV-2 in feces of patient with severe COVID-19 Survivability, Partitioning, and Recovery of Enveloped Viruses in Untreated Municipal Wastewater A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period Potential spreading risks and disinfection challenges of medical wastewater by the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) viral RNA in septic tanks of fangcang hospital 86 Disclaimers The views expressed in this article are those of the author(s) and do not necessarily represent the views or policies of the U.S. Environmental Protection Agency. The U.S. Environmental Protection Agency through the Office of Research and Development provided technical direction but did not collect, generate, evaluate We thank CSIRO Land and Water for strategic funding to complete this research project. We thank